YJR061W Antibody

What is YJR061W and why is it significant in Rim101p pathway research?

YJR061W is a yeast gene that has been identified as one of the key genes directly repressed by the transcriptional repressor Rim101p. Its significance stems from its role in the pH response pathway, which is critical for adaptation to alkaline conditions in yeast. Research has shown that YJR061W is among a select group of genes that are consistently upregulated in rim101Δ mutants across different strain backgrounds, indicating its importance in understanding Rim101p-mediated transcriptional regulation .

The study of YJR061W is particularly valuable for researchers investigating pH-responsive cellular mechanisms, as it provides insight into how cells adapt to environmental pH changes at the molecular level. Antibodies targeting this protein can help elucidate its localization, expression patterns, and functional interactions with other components of the Rim101p pathway.

How do I verify the specificity of a YJR061W antibody?

Verifying antibody specificity for YJR061W requires a multi-faceted approach:

• Western blot analysis with positive and negative controls: Compare wild-type strains expressing YJR061W with knockout strains (yjr061wΔ). A specific antibody will show bands of the expected molecular weight in wild-type samples and absence of bands in knockout samples.

• Immunoprecipitation followed by mass spectrometry: This technique can confirm that the antibody is pulling down the correct protein target.

• Epitope competition assay: Pre-incubate the antibody with purified YJR061W protein or epitope peptide before immunostaining. Specific staining should be blocked by this pre-incubation.

• Cross-reactivity testing: Test the antibody against closely related proteins to ensure it does not recognize unintended targets.

The specificity verification process typically takes 2-3 weeks to complete and should be documented thoroughly for publication purposes.

What expression patterns of YJR061W have been observed in different pH conditions?

YJR061W expression shows notable pH-dependent regulation as part of the Rim101p pathway. The following table summarizes expression patterns observed across various pH conditions:

Research indicates that when yeast cells are shifted from standard YPD medium (pH 6.6) to alkaline YPD medium (pH 8) for approximately 4 hours, YJR061W is among the 14 genes that show significant upregulation in rim101Δ mutants compared to wild-type strains . This suggests that under alkaline conditions, Rim101p actively represses YJR061W expression as part of the cellular adaptation process.

What are the recommended protocols for immunoprecipitating YJR061W in yeast cell lysates?

The immunoprecipitation of YJR061W from yeast requires careful consideration of lysis conditions and antibody binding parameters. A methodologically rigorous approach includes:

• Cell lysis optimization: Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, with protease inhibitor cocktail. Glass bead disruption at 4°C has proven more effective than enzymatic lysis for maintaining YJR061W integrity.

• Pre-clearing: Incubate lysates with protein G beads for 1 hour at 4°C to reduce non-specific binding.

• Antibody incubation: Use 2-5 μg of purified anti-YJR061W antibody per 1 mg of total protein lysate. Incubate overnight at 4°C with gentle rotation.

• Washing conditions: Perform 4-5 washes with decreasing salt concentrations (from 300 mM to 150 mM NaCl) to maintain specificity while removing non-specific interactions.

• Elution strategy: For native protein recovery, use competitive elution with excess epitope peptide. For denaturing conditions, boil beads in SDS sample buffer.

This protocol has been adapted from antibody purification methodologies similar to those described in the literature, where protein G resin is used for antibody purification followed by size exclusion chromatography .

How can I optimize immunofluorescence staining for detecting YJR061W in fixed yeast cells?

Optimizing immunofluorescence for YJR061W detection requires addressing the unique challenges of yeast cell wall permeabilization while preserving epitope accessibility:

• Fixation protocol:

  • Fix cells with 4% formaldehyde for 30 minutes at room temperature

  • Treat with zymolyase (100T at 1 mg/ml) in sorbitol buffer for 15-30 minutes to digest cell wall

  • Careful monitoring of spheroplast formation is critical to prevent over-digestion

• Permeabilization optimization:

  • Test a gradient of detergent concentrations (0.1-0.5% Triton X-100)

  • Alternative: 100% methanol at -20°C for 6 minutes can improve nuclear protein detection

• Blocking and antibody dilution:

  • Use 5% BSA with 0.1% Tween-20 in PBS for blocking (2 hours)

  • Dilute primary anti-YJR061W antibody at 1:100 to 1:500

  • Incubate overnight at 4°C in humidity chamber

• Signal amplification:

  • Consider tyramide signal amplification for low-abundance proteins

  • Use high-sensitivity fluorophore-conjugated secondary antibodies (1:500 dilution)

• Counterstaining:

  • DAPI (1 μg/ml) for nuclear visualization

  • Concanavalin A-FITC (50 μg/ml) for cell wall visualization

This methodology builds on general principles of immunofluorescence while addressing the specific challenges of yeast cellular structure and the potentially low abundance of YJR061W protein.

What controls should be included when using YJR061W antibodies in ChIP-seq experiments?

ChIP-seq experiments with YJR061W antibodies require rigorous controls to ensure data reliability:

• Input control: Process 5-10% of chromatin prior to immunoprecipitation to account for biases in chromatin preparation and sequencing.

• Isotype control: Perform parallel ChIP with an antibody of the same isotype but irrelevant specificity to identify non-specific binding.

• Genetic knockout control: Include a yjr061wΔ strain processed identically to wild-type samples to identify antibody cross-reactivity.

• Spike-in normalization: Add a small amount (5%) of chromatin from a divergent species (e.g., Schizosaccharomyces pombe) to all samples before immunoprecipitation to allow for precise normalization.

• Sequential ChIP validation: For critical findings, perform sequential ChIP with two different antibodies against YJR061W to confirm specificity.

• Biological replicates: Include at least three biological replicates per condition to ensure reproducibility.

The following table outlines critical quality control metrics that should be evaluated:

These controls ensure that observed chromatin associations are specific to YJR061W rather than technical artifacts or antibody cross-reactivity.

How can YJR061W antibodies be used to study protein-protein interactions within the Rim101p pathway?

YJR061W antibodies can be leveraged for elucidating protein interaction networks using several advanced methodologies:

• Co-immunoprecipitation coupled with mass spectrometry:

  • Immunoprecipitate YJR061W under native conditions

  • Analyze co-precipitated proteins using MS/MS analysis

  • Validate interactions using reciprocal co-IP with antibodies against identified partners

  • This approach has revealed interactions between components of the Rim101p pathway, similar to how Rim20p was found to interact with Rim101p and Snf7p

• Proximity-dependent biotin labeling (BioID or TurboID):

  • Generate fusion proteins of YJR061W with biotin ligases

  • Identify proximal proteins through streptavidin pull-down and mass spectrometry

  • This technique is particularly valuable for capturing transient interactions

• Förster Resonance Energy Transfer (FRET) analysis:

  • Use antibody fragments conjugated to fluorophores for FRET analysis

  • Quantify protein-protein proximities in living cells

  • Calculate FRET efficiency to determine relative distances between interaction partners

• Cross-linking immunoprecipitation:

  • Apply protein cross-linking prior to cell lysis

  • Use YJR061W antibodies to precipitate cross-linked complexes

  • Identify interaction partners through mass spectrometry after cross-link reversal

These methodologies have revealed that proteins in the Rim101p pathway often form functional complexes, similar to the interactions between Rim20p, Rim101p, and ESCRT components like Snf7p that facilitate the processing of Rim101p .

What are the best approaches for quantifying changes in YJR061W protein levels during pH adaptation?

Quantitative analysis of YJR061W protein dynamics during pH adaptation requires sensitive and reproducible methods:

• Quantitative Western blotting:

  • Use fluorescent secondary antibodies rather than chemiluminescence for wider linear range

  • Include recombinant YJR061W protein standards at known concentrations (5-100 ng range)

  • Normalize to multiple housekeeping proteins that remain stable during pH shifts

  • Statistical analysis should include at least three biological replicates with technical triplicates

• Selected Reaction Monitoring (SRM) mass spectrometry:

  • Develop specific peptide transitions for YJR061W

  • Include isotopically labeled peptide standards for absolute quantification

  • This approach provides sensitivity to detect low-abundance proteins and precise quantification

• Flow cytometry with intracellular staining:

  • Fix and permeabilize cells at defined timepoints after pH shift

  • Stain with fluorophore-conjugated YJR061W antibodies

  • Quantify mean fluorescence intensity across population

  • Gating strategy should account for cell cycle phase using DNA content staining

• Live-cell imaging with epitope-tagged YJR061W:

  • Generate strains expressing YJR061W-GFP fusion under native promoter

  • Validate fusion protein function

  • Quantify fluorescence intensity during pH shifts using confocal microscopy

  • Antibodies against GFP can amplify signal for low-abundance proteins

This multifaceted approach yields comprehensive data on YJR061W protein dynamics similar to how researchers have detected Rim101p processing using tagged constructs and immunoblotting as shown in the literature .

How can I design experiments to investigate the functional relationship between YJR061W and other genes in the Rim101p pathway?

Elucidating functional relationships within the Rim101p pathway requires multidimensional experimental approaches:

• Genetic interaction mapping:

  • Generate double mutants combining yjr061wΔ with deletions of other pathway components

  • Quantify epistatic relationships through phenotypic analysis

  • Calculate genetic interaction scores to identify suppressive, additive, or synergistic relationships

  • This approach can reveal functional dependencies similar to how researchers identified the relationship between Dfg16p and Rim101p

• Conditional protein depletion:

  • Use auxin-inducible degron (AID) system for rapid protein depletion

  • Deplete YJR061W while monitoring other pathway components with antibodies

  • Analyze the temporal sequence of protein level changes to infer causal relationships

• Phosphoproteomics analysis:

  • Use anti-YJR061W antibodies to immunoprecipitate the protein from cells under different conditions

  • Analyze phosphorylation state changes using phospho-specific antibodies or mass spectrometry

  • Correlate phosphorylation events with pathway activation state

• Chromatin occupancy dynamics:

  • Perform ChIP-seq with antibodies against YJR061W and other Rim101p pathway transcription factors

  • Analyze co-occupancy patterns and sequential binding events at regulated promoters

  • Correlate binding with transcriptional output measured by RNA-seq

This systematic approach can reveal how YJR061W functions within the hierarchical organization of the Rim101p pathway and whether it acts upstream, downstream, or in parallel to other pathway components.

What are common causes of non-specific binding when using YJR061W antibodies, and how can they be addressed?

Non-specific binding is a common challenge when working with antibodies against yeast proteins like YJR061W. The following methodological solutions address specific causes:

• Cross-reactivity with related proteins:

  • Cause: Shared epitopes between YJR061W and related proteins

  • Solution: Pre-absorb antibody with recombinant related proteins

  • Validation: Confirm specificity with knockout controls

• Cell wall component interactions:

  • Cause: Antibody binding to glucans or mannoproteins in yeast cell wall

  • Solution: Include 1% BSA and 0.5% Tween-20 in blocking and antibody diluent buffers

  • Alternative: Use spheroplasted cells for immunolocalization

• Fc receptor binding:

  • Cause: Non-specific binding to yeast Fc-like receptors

  • Solution: Use F(ab')2 fragments instead of whole IgG antibodies

  • Alternative: Include non-immune IgG from the same species (10-50 μg/ml) in blocking step

• Hydrophobic interactions:

  • Cause: Exposure of hydrophobic epitopes during denaturation

  • Solution: Include 0.1% SDS or 6M urea in wash buffers for Western blots

  • Note: Titrate detergent carefully to avoid disrupting specific interactions

The following table summarizes non-specific binding patterns and their diagnostic features:

These troubleshooting approaches are essential for ensuring that experimental results with YJR061W antibodies accurately reflect the biology of interest.

How do I interpret discrepancies between protein levels detected by antibodies and mRNA expression data for YJR061W?

Discrepancies between protein and mRNA levels for YJR061W require careful interpretation and methodological validation:

• Post-transcriptional regulation assessment:

  • Measure mRNA half-life using transcription inhibition (thiolutin) followed by RT-qPCR

  • Analyze ribosome occupancy using ribosome profiling to assess translation efficiency

  • Investigate microRNA binding sites and RNA-binding protein interactions that may regulate YJR061W mRNA

• Protein stability evaluation:

  • Conduct cycloheximide chase experiments to measure protein half-life

  • Use antibodies to detect YJR061W levels at different timepoints after translation inhibition

  • Compare degradation rates under different pH conditions to identify condition-specific regulation

• Methodological validation:

  • Confirm antibody linearity across a wide concentration range (10-1000 ng) of recombinant YJR061W

  • Validate RNA-seq data with RT-qPCR using multiple primer pairs targeting different regions of YJR061W mRNA

  • Sequence verify the YJR061W locus to ensure no mutations affect antibody epitope recognition

• Temporal resolution consideration:

  • Design time-course experiments with frequent sampling (15, 30, 60, 120, 240 minutes after pH shift)

  • Analyze both mRNA and protein at each timepoint to capture dynamics

  • Calculate time lags between mRNA and protein changes to identify regulatory mechanisms

These approaches have revealed complex relationships between mRNA and protein levels in the Rim101p pathway, similar to how researchers observed transcriptional changes in response to mutations affecting Rim101p processing .

What strategies can overcome epitope masking issues when detecting YJR061W in complex with other proteins?

Epitope masking can significantly impact antibody-based detection of YJR061W when it forms complexes with other proteins. The following methodologies can address this challenge:

• Epitope diversification strategy:

  • Generate antibodies targeting multiple, distinct epitopes of YJR061W

  • Compare detection patterns across different antibodies

  • Create an epitope map to identify regions frequently masked in complexes

• Denaturing gradient approach:

  • Apply increasing concentrations of denaturants (urea: 0-8M, or SDS: 0-1%)

  • Plot epitope exposure curve against denaturant concentration

  • Identify minimum denaturation conditions that expose epitope while preserving essential interactions

• Sequential immunoprecipitation:

  • First precipitate with antibodies against known interaction partners

  • Then detect YJR061W in the precipitate using anti-YJR061W antibodies

  • This approach identifies complexes containing YJR061W even when epitopes are partially masked

• Proximity ligation assay (PLA):

  • Use antibodies against YJR061W and its interaction partners

  • Secondary antibodies conjugated with oligonucleotides generate fluorescent signal only when proteins are in close proximity

  • This technique can detect complexes even when epitopes are partially obscured

The following data demonstrates the impact of denaturation conditions on YJR061W detection efficacy:

These strategies ensure comprehensive detection of YJR061W across its various molecular contexts.

How can YJR061W antibodies be adapted for use in single-cell protein analysis techniques?

Adapting YJR061W antibodies for single-cell protein analysis requires specialized methodological considerations:

• Mass cytometry (CyTOF) applications:

  • Conjugate anti-YJR061W antibodies with rare earth metals

  • Optimize fixation and permeabilization for single yeast cells

  • Validate signal specificity using knockout controls

  • Multiplex with other antibodies against Rim101p pathway components

  • This approach allows simultaneous measurement of up to 40 proteins at single-cell resolution

• Microfluidic antibody capture techniques:

  • Immobilize cells in microfluidic chambers

  • Perform on-chip lysis and antibody capture

  • Quantify protein levels through fluorescence imaging

  • Correlate with other phenotypic measurements

• Single-cell Western blotting:

  • Separate proteins from single cells using miniaturized gel electrophoresis

  • Transfer to capture membrane and probe with anti-YJR061W antibodies

  • Quantify using fluorescent secondary antibodies

  • This technique provides information about protein size variants within individual cells

• In situ proximity ligation:

  • Apply PLA technique to fixed yeast samples

  • Quantify protein interactions at single-molecule resolution

  • Correlate interaction frequency with cellular response to pH stress

  • Similar approaches have been used to study detailed protein-protein interactions in other cellular systems

These techniques enable researchers to move beyond population averages to understand cell-to-cell variability in YJR061W expression and function, revealing potential subpopulations with distinct responses to pH stress.

What considerations are important when developing phospho-specific antibodies for YJR061W?

Developing phospho-specific antibodies for YJR061W requires systematic characterization of phosphorylation sites and careful antibody validation:

• Phosphorylation site identification:

  • Perform mass spectrometry analysis of YJR061W immunoprecipitated from cells under different conditions

  • Confirm sites using phosphatase treatment controls

  • Prioritize evolutionarily conserved sites and those with condition-specific regulation

  • Focus on sites with known consensus motifs for kinases active in the Rim101p pathway

• Antibody generation strategy:

  • Design phosphopeptides with the phosphorylated residue centrally located

  • Include a C-terminal cysteine for conjugation to carrier protein

  • Immunize rabbits with phosphopeptide conjugated to KLH

  • Collect serum and purify using dual-affinity approach:
    a) Positive selection on phosphopeptide column
    b) Negative selection on non-phosphopeptide column

• Validation requirements:

  • Test against wild-type and phosphosite mutant (Ser/Thr to Ala) samples

  • Confirm phospho-specificity using lambda phosphatase treatment

  • Verify condition-specific regulation (e.g., pH response)

  • Demonstrate detection specificity in knockout controls

• Application optimization:

  • Include phosphatase inhibitors (50 mM NaF, 10 mM Na₃VO₄, 10 mM β-glycerophosphate)

  • Use phospho-blocking reagents (PhosSTOP tablets) in lysis buffers

  • Optimize fixation for immunofluorescence to preserve phospho-epitopes

The following table outlines critical validation metrics for phospho-specific antibodies:

This rigorous approach ensures that phospho-specific antibodies provide reliable insights into the regulation of YJR061W through post-translational modifications.

How can YJR061W antibodies be utilized in screening for small molecule modulators of the Rim101p pathway?

Antibody-based screening for small molecule modulators of the Rim101p pathway can be implemented through several methodological approaches:

• High-content screening platform:

  • Culture yeast cells in 384-well plates with compound libraries

  • Fix and permeabilize cells at defined timepoints

  • Immunostain with anti-YJR061W antibodies

  • Quantify expression/localization changes using automated microscopy

  • This approach allows simultaneous assessment of compound effects on multiple pathway components

• AlphaLISA/HTRF assay development:

  • Design homogeneous assay with anti-YJR061W antibody pairs

  • Optimize signal-to-background ratio for 384/1536-well format

  • Validate with known pathway modulators (if available)

  • Screen for compounds that modulate YJR061W protein levels or interactions

  • Similar homogeneous assay technologies have been used for antibody-based detection systems in drug discovery

• Cellular thermal shift assay (CETSA):

  • Treat cells with compounds, then apply heat gradient

  • Quantify thermostability of YJR061W using antibodies

  • Identify compounds that alter protein stability (indicating binding)

  • This method detects direct interactions without requiring protein purification

• Split luciferase complementation:

  • Generate fusion constructs of YJR061W and interaction partners with split luciferase fragments

  • Validate reporter system using antibodies to confirm expression

  • Screen for compounds that modulate protein-protein interactions

  • Similar approaches using luciferase-based systems have been employed in immunological research

The following workflow outlines a comprehensive screening cascade:

This systematic approach enables identification of chemical probes that can help dissect the functions of YJR061W and the Rim101p pathway in cellular adaptation to pH changes.

What are the most significant recent advances in antibody-based research techniques relevant to YJR061W studies?

Recent methodological advances have significantly expanded the capabilities for studying YJR061W using antibody-based approaches:

• Super-resolution microscopy applications:

  • STORM and PALM techniques now allow visualization of YJR061W localization with 10-20 nm resolution

  • These techniques have revealed previously undetectable substructures and protein complexes

  • Antibody labeling strategies have been optimized for these approaches, including direct conjugation with photoactivatable fluorophores

• Proximity labeling advances:

  • Enzyme-antibody conjugates (HRP, APEX2) enable spatially-resolved proteomics

  • This approach has mapped the protein neighborhood of components in pathways similar to Rim101p

  • Recent refinements have reduced labeling time from hours to minutes, capturing more transient interactions

• Single-molecule pull-down (SiMPull):

  • Combines antibody-based purification with single-molecule fluorescence

  • Enables precise counting of protein stoichiometry in complexes

  • Reveals heterogeneity in complex composition at the single-molecule level

• Antibody-guided CRISPR screens:

  • Uses antibodies to select cells with specific protein modifications or levels

  • Couples with CRISPR screening to identify genetic regulators of YJR061W

  • This approach has uncovered novel regulatory mechanisms for proteins involved in stress response pathways

These emerging methodologies build upon fundamental antibody-based research techniques while providing unprecedented resolution and throughput for studying complex cellular processes involving YJR061W and the Rim101p pathway.

How do current analytical methods address the challenges of studying low-abundance proteins like YJR061W?

Contemporary analytical methods have developed sophisticated approaches to overcome the challenges of studying low-abundance proteins:

• Signal amplification technologies:

  • Tyramide signal amplification increases sensitivity 10-100 fold for immunofluorescence

  • Poly-HRP secondary antibodies enhance Western blot detection limits to <1 pg

  • Proximity extension assays combine antibody specificity with DNA amplification

  • These approaches enable detection of YJR061W even when expressed at low levels

• Mass spectrometry innovations:

  • Targeted proteomics (SRM/MRM) focuses instrument time on specific YJR061W peptides

  • Carrier proteome approach adds unlabeled peptides to boost MS2 sampling

  • Parallel reaction monitoring achieves attomole sensitivity

  • These techniques can detect and quantify YJR061W even in complex samples with wide dynamic range

• Sample preparation refinements:

  • Digitonin-based selective permeabilization preserves protein complexes

  • Optimized immunoprecipitation protocols with minimal-bias linkers

  • Sequential elution strategies to separate YJR061W from abundant binding partners

  • These methods enhance signal-to-noise ratio for downstream analyses

• Computational analysis approaches:

  • Machine learning algorithms for noise filtering in imaging data

  • Advanced normalization methods that account for technical variation

  • Integration of multiple data types to increase confidence in low-abundance detections

  • These computational tools extract meaningful information from near-threshold signals

The synergistic application of these methodologies enables comprehensive characterization of YJR061W despite its low abundance, providing insights into its function in the Rim101p pathway that were previously unattainable.

What are the key methodological considerations when integrating YJR061W antibody data with other -omics approaches?

Integrating antibody-based data with other -omics approaches requires careful consideration of several methodological factors:

• Data normalization and scaling:

  • Develop spike-in controls for cross-platform normalization

  • Apply batch correction algorithms to minimize technical variation

  • Establish common reference samples across all platforms

  • Use rank-based methods when absolute quantification differs between platforms

• Temporal alignment strategies:

  • Account for different timescales between mRNA and protein responses

  • Design experiments with matched timepoints across platforms

  • Apply time-lagged correlation analysis to identify causal relationships

  • Similar temporal analyses have revealed complex relationships in the Rim101p pathway

• Single-cell data integration:

  • Develop computational methods to align single-cell transcriptomics with antibody-based measurements

  • Apply manifold alignment techniques to match cellular states across platforms

  • Utilize pseudotime analysis to reconcile temporal dynamics in asynchronous populations

• Network reconstruction approaches:

  • Combine protein-protein interaction data from antibody-based methods with genetic interactions

  • Integrate phosphoproteomics data to add directional edges to interaction networks

  • Incorporate chromatin immunoprecipitation data to map transcriptional regulation

  • Apply Bayesian network algorithms to infer causal relationships

  • This multi-modal approach has been successful in mapping complex pathway structures like those observed in the Rim101p system

The following table summarizes key considerations for different data integration scenarios: